The role of topical retinoids in the treatment of photoaging

Drugs

Volumn 65, Issue 8, 2005, Pages 1061-1072

  Stratigos, Alexander J ^a   Katsambas, Andreas D ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ANDREAS SYGROS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR RETINOL BINDING PROTEIN; HYDROCORTISONE; INDOMETACIN; ISOTRETINOIN; MELANIN; PROTEIN CELLULAR RETINOIC ACID BINDING PROTEIN; RETINAL; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; RETINOID X RECEPTOR GAMMA; RETINOL; TAZAROTENE; UNCLASSIFIED DRUG; VITAMIN BINDING PROTEIN;

ACTINIC KERATOSIS; CLINICAL TRIAL; CONJUNCTIVITIS; DERMATITIS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; EPIDERMIS; ERYTHEMA; FETUS MALFORMATION; HUMAN; HYPERPIGMENTATION; LENTIGO; NONHUMAN; PHOTOAGING; PHOTOSENSITIVITY; PRURITUS; REVIEW; SIDE EFFECT; SKIN ABRASION; SKIN BURNING SENSATION; SKIN IRRITATION; STRATUM CORNEUM; TELANGIECTASIA; TERATOGENICITY; TREATMENT OUTCOME; ULTRAVIOLET RADIATION; WRINKLE; XEROSIS;

ADMINISTRATION, TOPICAL; ANIMALS; HUMANS; RETINOIDS; SKIN AGING;

EID: 20544456646     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200565080-00003     Document Type: Review

References (66)

1. Peck GL, DiGiovanna JJ. The retinoids. In: Freedberg IM, Eisen AZ, Wolff K, et al., editors. Fitzpatrick's dermatology in general medicine. 5th ed. New York: McGraw-Hill Professional, 1999: 2810-20
2. Tobin CJ. Retinoids, homeoboxes and growth factors toward molecular models for limb development. Cell 1991; 66: 199-217
3. Siegenthaler G, Saurat J-H, Ponec M. Retinol and retinal metabolism: relationship to the state of differentiation of cultured human keratinocytes. Biochem J 1990; 268: 371-8
4. Duell EA, Astrom A, Griffiths CEM, et al. Human skin levels of retinoic acid and cytochrome p-450-derived-hydroxyretinoic acid after topical application of retinoic acid receptor-mediated transcription in vitro. J Clin Invest 1992; 90: 1269-74
5. Torras H. Retinoids in aging. Dermatol Clin 1996; 14: 207-15
6. Kligman A, Fulton Jr JE, Plewig G. Topical vitamin A acid in acne vulgaris. Arch Dermatol 1969; 99: 469-76
7. Cordero A. La vitamina A acida en la piel senil. Actua Ter Dermatol 1983; 6: 49-54
8. Kligman LH. Effects of all-trans-retinoic acid on the dermis of hairless mice. J Am Acad Dermatol 1986; 15: 779-85
9. Kligman AM, Grove GZ, Hirose R, et al. Topical tretinoin for photoaged skin. J Am Acad Dermatol 1986; 15: 836-59
10. Gilchrest BA. Skin aging 2003: recent advances and current concepts. Cutis 2003; 72 (3 Suppl.): 5-10
11. Fenske NA, Lober CW. Structural and junctional changes of normal aging skin. J Am Acad Dermatol 1986; 13: 571-85
12. Montagna W, Carlisle K. Structural changes in aging human skin. J Invest Dermatol 1979; 73: 47-53
13. Lavker EIM, Zheng PS, Dong G. Aged skin: a study by light, transmission electron and scanning electron microscopy. J Invest Dermatol 1987; 88: 44s-51s
14. Lavker RM. Cutaneous aging: chronologic versus photoaging. In: Gilchrest BA, editor. Photodamage. Cambridge (MA): Blackwell Science Inc., 1995: 123-35
15. Kligman AM. Early destructive effects of sunlight on human skin. JAMA 1969; 210: 2377-80
16. Lavker RM, Kligman AM. Chronic heliodermatitis: a morphologic evaluation of chronic dermal damage with emphasis on the role of mast cells. J Invest Dermatol 1988; 90: 325-30
17. Astrom A, Tavakkol A, Pettersson U, et al. Molecular cloning of two human cellular retinoic acid-binding proteins (CRABP). J Biol Chem 1991; 266: 17662-6
18. Eller MS, Oleksiak MF, McQuaid TJ, et al. The molecular cloning and expression of two CRABP cDNAs from human skin. Exp Cell Res 1992; 199: 328-36
19. Petkovich M, Brand MJ, Krust A, et al. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987; 330: 444-50
20. Brand N, Petkovich M, Krust A, et al. Identification of a second human retinoic acid receptor. Nature 1988; 332: 850-3
21. Krust A, Kastner P, Petkovich M. et al. A third human retinoic acid receptor hRAR-γ. Proc Natl Acad Sci U S A 1989; 86: 5310-4
22. Manglesdorf DJ, Ong ES, Dyck JA, et al. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 1990; 345: 224-9
23. Rees JL, Redfern CPF. Expression of the α and β retinoic acid receptors in skin. J Invest Dermatol 1989; 92: 818-20
24. Nagpal S, Saunders M, Kastner P, et al. Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell 1992; 70: 1007-19
25. Gilchrest BA. Retinoids and photodamage. Br J Dermatol 1992; 127 Suppl. 41: 14-20
26. Griffiths CEM, Voorhees JJ. Effects of retinoids on photodamaged skin. In: Gilchrest BA, editor. Photodamage. Cambridge (MA): Blackwell Science Inc., 1995: 221-43
27. Griffiths CEM, Finkel LJ, Tranfaglia MG, et al. An in vivo experimental model for topical retinoid effects on human skin. Br J Dermatol 1993; 29: 389-99
28. Fisher GJ, Tavakkol A, Griffiths CEM, et al. Differential modulation of transforming growth factor β1 expression and mucin deposition by retinoic acid and sodium lauryl sulfate in human skin. J Invest Dermatol 1992; 98: 102-8
29. Griffiths CEM, Goldfarb MT, Finkel LJ, et al. Topical tretinoin (retinoic acid) treatment for hyperpigmented lesions associated with photoaging in Chinese and Japanese patients. J Am Acad Dermatol 1994; 30: 76-84
30. Orlow SJ, Chakraborty AK, Pawalek JM. Retinoic acid is a potent inhibitor of inducible pigmentation in murine and hamster melanoma cell lines. J Invest Dermatol 1990; 94: 461-4
31. Kligman AM, Zheng P, Lavker RM. The anatomy and pathogenesis of wrinkles. Br J Dermatol 1985; 113: 37-42
32. Griffiths CEM, Russman AN, Majmudar G, et al. Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid). N Engl J Med 1993; 329: 530-5
33. Fisher GJ, Wang ZQ, Datta SC, et al. Pahtophysiology of premature skion aging induced by ultraviolet radiation. N Engl J Med 1997; 337: 1419-28
34. Weiss JS, Ellis CN, Headington JT, et al. Topical tretinoin improves photoaged skin. JAMA 1988; 259: 527-3
35. Leyden JJ, Grove GL, Grove MJ, et al. Treatment of photodamaged skin with topical tretinoin. J Am Acad Dermatol 1989; 21: 638-44
36. Lever L, Kumar P, Marks R. Topical retinoic acid for the treatment of solar damage. Br J Dermatol 1990; 122: 91-8
37. Kang S, Voorhees JJ. Photoaging therapy with topical tretinoin: an evidence-based analysis. J Am Acad Dermatol 1998; 39: S55-61
38. Griffiths CEM, Kang S, Ellis CN, et al. Two concentrations of topical tretinoin (retinoic acid) cause similar improvement of photoaging but different degrees of irritation. Arch Dermatol 1995; 131: 1037-44
39. Weinstein GD, Nigra TP, Pochi PE, et al. Topical tretinoin for treatment of photodamaged skin: a multicenter study. Arch Dermatol 1991; 127: 659-65
40. Olsen EA, Katz I, Levine N, et al. Tretinoin emollient cream: a new therapy for photodamaged skin. J Am Acad Dermatol 1992; 26: 215-24
41. Green LJ, McCormick A, Weinstein GD. Photoaging and the skin: the effects of tretinoin. Dermatol Clin 1993; 11: 97-105
42. Ellis CN, Weiss JS, Hamilton TA, et al. Sustained improvement with prolonged topical tretinoin (retinoic acid) for photoaged skin. J Am Acad Dermatol 1990; 23: 629-37
43. Bhawan J, Olsen E, Lufrano L, et al. Histologic evaluation of the long-term effects of tretinoin on photodamaged skin. J Dermatol Sci 1996; 11: 177-82
44. Zelickson AS, Mottz JH, Weiss JS, et al. Topical tretinoin in photoaged skin: an ultrastructural study. J Cut Aging Cosm Dermatol 1988; 1: 41-7
45. Buchan P, Eckhoff C, Caron D, et al. Repeated topical administration of all-trans-retinoic acid and plasma levels of retinoic acids in humans. J Am Acad Dermatol 1994; 30: 428-34
46. Sendagorta E, Lesiewicz J, Armstrong RB. Topical isotretinoin for photodamaged skin. J Am Acad Dermatol 1992; 27: S15-8
47. Maddin S, Lauharanta J, Agache P, et al. Isotretinoin improves the appearance of photodamaged skin: results of a 36-week, multicenter, double-blind, placebo-controlled trial. J Am Acad Dermatol 2000; 42: 56-63
48. Alirezai M, Dupuy R, Amblard P, et al. Clinical evaluation of topical isotretinoin in the treatment of actinic keratoses. J Am Acad Dermatol 1994; 30: 447-51
49. Saurat JH, Didierjean L, Masgrau E, et al. Topical retinaldehyde on human skin: biological effects and tolerance. J Invest Dermatol 1994; 103: 770-4
50. Didierjean L, Tran C, Sorg O, et al. Biological activities of retinaldehyde. Dermatology 1999; 199 Suppl. 1: 19-24
51. Creidi P, Vienne MP, Ochonisky S, et al. Profilometric evaluation of photodamage after topical retinaldehyde and retinoic acid treatment. J Am Acad Dermatol 1998; 39: 960-5
52. Boisnic S, Branchet-Gumila MC, Le Charpentier Y, et al. Repair of UVA-induced elastic fiber and collagen damage by 0.05% retinaldehyde cream in an ex vivo human skin model. Dermatology 1999; 199 Suppl. 1: 43-8
53. Sefton J, Kligman AM, Kopper SC, et al. Photodamage pilot study: a double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1% gel. J Am Acad Dermatol 2000; 43: 656-63
54. Kang S, Leyden JJ, Lowe NJ. Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks. Arch Dermatol 2001; 137: 1597-604
55. Lowe N, Gifford M, Tanghetti E, et al. Tarazotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study. J Cosmet Laser Ther 2004; 6: 79-85
56. Phillips TJ, Gottlieb AB. Leyden JJ. et al. Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial. Arch Dermatol 2002; 138: 1486-93
57. Grove GL, Grove MJ, Leyden JJ, et al. Skin replica analysis of photodamaged skin after therapy with tretinoin emollient cream. J Am Acad Dermatol 1991; 25: 231-7
58. Kligman AM, Graham GF. Histological changes in facial skin after daily application oftretinoin for 5 to 6 years. J Dermatol Treat 1993; 4: 113-7
59. Grove GL, Grove MJ, Zerwick CR, et al. Determination of topical tretinoin effects on cutaneous microcirculation in photoaged skin by laser Doppler velocimetry. J Cut Aging Cosmet Dermatol 1988; 1: 27-33
60. Marks R, Hill S, Barton SP. The effects of an abrasive agent on normal skin and on photodamaged skin in comparison with topical tretinoin, Br J Dermatol 1990; 123: 457-66
61. Kligman AM, Dogadkina D, Lavker RM. Effects of topical tretinoin on non-sun-exposed protected skin of the elderly. J Am Acad Dermatol 1993; 39: 25-33
62. Katsambas AD, Katoulis AC. Topical retinoids in the treatment of aging of the skin. In: Mallia C, Uitto J, editors. RheumaDerm. New York: Kluwer Academic/Plenum Publishers, 1999: 477-82
63. Ortonne JP, Marks R. The treatment of skin photoaging. In: Ortonne JP, Marks R, editors. Photodamaged skin: clinical signs, causes, management. London: Martin Dunitz Ltd, 1999: 121-42
64. Krautheim A, Gollnick H. Transdermal penetration of topical drugs used in the treatment of acne. Clin Pharmacokinet 2003; 42: 1287-304
65. Kligman AM. Isotopical tretinoin teratogenic? [letter]. JAMA 1988; 259: 2918
66. Jick SJ, Terris BZ, Jick H. First trimester topical tretinoin and congenital disorders. Lancet 1993; 341: 1181-2